Apolipoprotein A5, a Crucial Determinant of Plasma Triglyceride Levels, Is Highly Responsive to Peroxisome Proliferator-activated Receptor ?? Activators, Journal of Biological Chemistry, vol.278, issue.20, pp.17982-17985, 2003. ,
DOI : 10.1074/jbc.M212191200
Peroxisome Proliferator-activated Receptor ?? Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-??B and AP-1, Journal of Biological Chemistry, vol.274, issue.45, pp.32048-32054, 1999. ,
DOI : 10.1074/jbc.274.45.32048
PPAR?? Activators Inhibit Cytokine-Induced Vascular Cell Adhesion Molecule-1 Expression in Human Endothelial Cells, Circulation, vol.99, issue.24, pp.3125-3131, 1999. ,
DOI : 10.1161/01.CIR.99.24.3125
Sorting out the roles of PPAR?? in energy metabolism and vascular homeostasis, Journal of Clinical Investigation, vol.116, issue.3, pp.571-580, 2006. ,
DOI : 10.1172/JCI27989DS1
Selective PPAR modulators, dual and pan PPAR agonists: multimodal drugs for the treatment of Type 2 diabetes and atherosclerosis, Expert Opinion on Emerging Drugs, vol.14, issue.3, pp.379-401, 2006. ,
DOI : 10.1074/jbc.M209629200
Identification of Nuclear Receptor Corepressor as a Peroxisome Proliferator-activated Receptor ?? Interacting Protein, Journal of Biological Chemistry, vol.274, issue.22, pp.15901-15907, 1999. ,
DOI : 10.1074/jbc.274.22.15901
From molecular action to physiological outputs: Peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions, Progress in Lipid Research, vol.45, issue.2, pp.120-159, 2006. ,
DOI : 10.1016/j.plipres.2005.12.002
A Natural Polymorphism in Peroxisome Proliferator-Activated Receptor-?? Hinge Region Attenuates Transcription due to Defective Release of Nuclear Receptor Corepressor from Chromatin, Molecular Endocrinology, vol.22, issue.5, pp.1078-1092, 2008. ,
DOI : 10.1210/me.2007-0547
Cooperative NCoR/SMRT interactions establish a corepressor-based strategy for integration of inflammatory and anti-inflammatory signaling pathways, Genes & Development, vol.23, issue.6, pp.681-693, 2009. ,
DOI : 10.1101/gad.1773109
Peroxisome Proliferator-activated Receptor alpha (PPARalpha ) Turnover by the Ubiquitin-Proteasome System Controls the Ligand-induced Expression Level of Its Target Genes, Journal of Biological Chemistry, vol.277, issue.40, pp.37254-37259, 2002. ,
DOI : 10.1074/jbc.M110598200
Phosphorylation of PPARs: from molecular characterization to physiological relevance, Biochimie, vol.87, issue.1, pp.33-38, 2005. ,
DOI : 10.1016/j.biochi.2004.11.010
The Journal of clinical investigation, pp.3138-3148, 2009. ,
Sumoylation regulates diverse biological processes, Cellular and Molecular Life Sciences, vol.64, issue.23, pp.3017-3033, 2007. ,
DOI : 10.1007/s00018-007-7137-4
Concepts in sumoylation: a decade on, Nature Reviews Molecular Cell Biology, vol.1773, issue.12, pp.947-956, 2007. ,
DOI : 10.1038/nrm2293
Molecular Characterization of New Selective Peroxisome Proliferator-Activated Receptor ?? Modulators With Angiotensin Receptor Blocking Activity, Diabetes, vol.54, issue.12, pp.3442-3452, 2005. ,
DOI : 10.2337/diabetes.54.12.3442
SUMO Modification of the Ets-related Transcription Factor ERM Inhibits Its Transcriptional Activity, Journal of Biological Chemistry, vol.280, issue.26, pp.24330-24338, 2005. ,
DOI : 10.1074/jbc.M411250200
Parallel SUMOylation-Dependent Pathways Mediate Gene- and Signal-Specific Transrepression by LXRs and PPAR??, Molecular Cell, vol.25, issue.1, pp.57-70, 2007. ,
DOI : 10.1016/j.molcel.2006.11.022
URL : http://doi.org/10.1016/j.molcel.2006.11.022
A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-??, Nature, vol.28, issue.7059, pp.759-763, 2005. ,
DOI : 10.1038/35056591
Transcriptional Activity of Peroxisome Proliferator-activated Receptor ?? Is Modulated by SUMO-1 Modification, Journal of Biological Chemistry, vol.279, issue.28, pp.29551-29557, 2004. ,
DOI : 10.1074/jbc.M403866200
PIAS proteins as regulators of small ubiquitin-related modifier (SUMO) modifications and transcription: Figure 1, Biochemical Society Transactions, vol.35, issue.6, pp.1405-1408, 2007. ,
DOI : 10.1042/BST0351405
SUMOylation of ROR?? potentiates transcriptional activation function, Biochemical and Biophysical Research Communications, vol.378, issue.3, pp.513-517, 2009. ,
DOI : 10.1016/j.bbrc.2008.11.072
Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1), Proceedings of the National Academy of Sciences, vol.97, issue.26, pp.14145-14150, 2000. ,
DOI : 10.1073/pnas.97.26.14145
The Aryl Hydrocarbon Receptor Nuclear Transporter Is Modulated by the SUMO-1 Conjugation System, Journal of Biological Chemistry, vol.277, issue.48, pp.46576-46585, 2002. ,
DOI : 10.1074/jbc.M205987200
An extended consensus motif enhances the specificity of substrate modification by SUMO, The EMBO Journal, vol.579, issue.21, pp.5083-5093, 2006. ,
DOI : 10.1038/sj.emboj.7601383
Cross Talk of Signaling Pathways in the Regulation of the Glucocorticoid Receptor Function, Molecular Endocrinology, vol.22, issue.6, pp.1331-1344, 2008. ,
DOI : 10.1210/me.2007-0360
Aspects of the regulatory mechanisms of PPAR functions: Analysis of a bidirectional response element and regulation by sumoylation, Molecular and Cellular Biochemistry, vol.175, issue.1-2, pp.33-42, 2006. ,
DOI : 10.1007/s11010-005-9052-z
SUMOylation of Kr??ppel-like transcription factor 5 acts as a molecular switch in transcriptional programs of lipid metabolism involving PPAR-??, Nature medicine, vol.103, issue.6, pp.656-666, 2008. ,
DOI : 10.1038/nm1756